Takeda Pharmaceutical Non-GAAP EPS of ¥517.00, revenue of ¥4505.7B; gives FY2026 forecast
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · Now $15.19
-2.3% in 7d after detection
Post-detection moves
1h
—
1d
-0.1%
3d
-0.4%
7d
-2.3%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS